Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended on June 30 2024 as per Regulation 33 of the Listing Regulation and Any other item of business as may be decided by the board of directors of the company